Pharmacoepidemiology Study Design & Safety Signal Assessment
Design pharmacoepidemiology studies to assess drug safety signals
What You Can Do
You can design rigorous observational and retrospective cohort studies that meet FDA and EMA regulatory standards, complete with detailed statistical analysis plans and safety assessment frameworks. Claude generates structured study protocols, pre-specifies safety signal detection methodologies, and produces regulatory-ready documentation that accelerates your pathway from research hypothesis to pharmacovigilance submission.
Features
Generate comprehensive protocols with study population definitions, inclusion/exclusion criteria, and outcome specifications aligned with ICH-GCP standards
Systematize adverse event detection using disproportionality analysis, temporal relationship assessment, and dose-response evaluation frameworks
Structure pre-specified statistical approaches including propensity score matching, instrumental variables, and confounder adjustment strategies
Produce agency-ready study synopses, statistical analysis summaries, and safety update narratives formatted for FDA/EMA submission
Develop REMS and risk evaluation frameworks based on signal severity, population vulnerability, and benefit-risk assessment matrices
Generate validation workflows for cohort definitions, outcome classification, and medication exposure ascertainment across healthcare databases
Construct structured frameworks for comparative effectiveness and safety profiling across therapeutic alternatives
Example Output
Study Protocol Excerpt:
- Population: Patients aged ≥18 with diagnosis code [ICD-10] initiating [drug name], excluding prior use in last 12 months
- Primary outcome: Hospitalization for [adverse event], defined by claims/EHR codes [list], with 30-day lookback
- Statistical analysis: Propensity score adjustment using logistic regression (14 baseline covariates), stratified Cox regression with 95% CI estimation
Safety Signal Report:
- Disproportionality: ROR = 2.4 (95% CI: 1.8–3.1) for hepatotoxicity in VigiBase™ 2024 subset
- Temporal assessment: Median onset 45 days post-initiation; rechallenge data supports causality (Naranjo score 7/9)
- Recommendation: Add hepatic impairment to contraindications section; implement liver function monitoring protocol
Regulatory REMS Documentation:
- ETASU requirements: Risk-benefit profile justifies restricted distribution; recommend risk categorization framework and provider certification pathway
What's Included
- SKILL.md: Complete pharmacoepi study design methodology, signal assessment decision trees, and regulatory mapping
- Study Protocol Template: ICH-GCP compliant protocol structure with outcome and covariate specifications
- Safety Signal Assessment Checklist: Disproportionality analysis, temporal relationship, dose-response evaluation workflow
- Statistical Analysis Plan Template: Pre-specified statistical approaches with sensitivity analysis matrices
- Regulatory Submission Framework: FDA Form 1571, EMA CTD safety summary structure, and REMS documentation templates
- Data Quality Validation Checklist: Cohort definition validation, outcome classification verification, exposure ascertainment audit trail
- Comparative Safety Analysis Worksheet: Structured framework for multi-drug safety profiling
- Example Study Protocols: Real-world redacted protocol examples across indication types
Who It's For
- Pharmacoepidemiologists — Design observational studies and execute post-market surveillance programs
- Clinical Safety Officers — Assess emerging safety signals and develop risk minimization strategies
- Regulatory Affairs Specialists — Prepare agency submissions with pre-defined protocols and statistical plans
- Medical Affairs Teams — Support comparative safety assessments and REMS documentation
- Academic Researchers — Develop grant applications and study protocols for drug safety research
Best For
- Designing post-approval pharmacoepidemiology studies for FDA/EMA reporting
- Assessing and characterizing drug safety signals from spontaneous reporting or claims data
- Pre-specifying statistical analysis plans and study protocols before data access
- Developing Risk Evaluation and Mitigation Strategy (REMS) frameworks and justifications
- Conducting comparative safety analyses across competing therapeutic agents
You might also like
You can create comprehensive, evidence-based workplace wellness programs tailored to your organization's culture and employee needs. The skill helps you develop strategic initiatives with measurable objectives, employee engagement strategies, and ROI metrics that demonstrate program value to leadership. You'll produce complete program designs including needs assessments, activity recommendations, communication plans, and health metrics dashboards.
This skill generates detailed, customized emergency preparedness plans tailored to your specific location, threats, and organizational needs. It creates actionable response protocols, supply checklists, communication procedures, and evacuation strategies. You get a complete, ready-to-implement emergency framework for households, businesses, schools, or community organizations.
You design comprehensive disease outbreak investigation protocols customized to your pathogen, region, and available resources. Claude generates structured investigation plans with case finding strategies, team briefings, timeline documentation, and coordination guidance—enabling you to move from initial detection to coordinated response in hours instead of days. Each plan includes case definitions, laboratory workflows, surveillance enhancements, and escalation criteria.
Coordinate rapid disease outbreak investigations and generate required public health reports. You get structured case management workflows, epidemiological analysis templates, and compliance-ready documentation for state and local health agencies. Streamline investigations, alert protocols, and notification timelines to meet CDC and state reporting requirements.
You can rapidly design and evaluate evidence-based community health programs that address specific health priorities for your target population. The framework guides you through needs assessment, intervention selection, implementation planning, and evaluation design—helping you create programs that are both effective and equitable. You'll generate detailed implementation roadmaps, resource plans, and sustainability strategies that stakeholders can execute immediately.
This skill helps you investigate emerging health threats across the globe by analyzing outbreak data, identifying patterns, and assessing transmission risks. You can synthesize disease surveillance information, geographic spread analysis, and epidemiological modeling to create comprehensive situation reports that support rapid response decisions.
Design comprehensive chronic disease prevention interventions that integrate behavior change theory with population-specific tailoring. You'll generate evidence-based strategies for diabetes, heart disease, obesity, and other chronic conditions, complete with implementation blueprints and measurable health outcomes. Each intervention is customized for your target population's demographics, social determinants, and readiness to change.
You'll create comprehensive, data-driven workplace wellness programs tailored to your organization's unique needs and constraints. Claude helps you establish clear health goals, design evidence-backed interventions, define success metrics, and build sustainable implementation strategies—complete with stakeholder communication plans and ROI projections. Whether launching a new program or improving an existing one, you get actionable frameworks backed by health research.